Screening for Studies on Autism Spectrum Disorders
This study will screen children and adolescents (and their parents) to determine the child's eligibility for participation in NIMH research studies on autism spectrum disorders, such as autism and Rett's Disorder.
Screening evaluations include some or all of the following procedures:
Parent and child evaluations including:
- Diagnostic interview
- Developmental or cognitive testing
- Ratings of psychiatric and medical symptoms
- Neuropsychological testing
- Personal, social an family history
Child physical examination and possible blood draw
Children who are determined eligible for a current NIMH research protocol are invited to participate.
Autism Spectrum Disorders
|Official Title:||Screening Protocol for Studies of the Pediatrics and Developmental Neuroscience Branch|
|Study Start Date:||December 2005|
The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorders. The evaluations will help determine if the participant meets criteria for participation in research protocols of the Pediatric and Developmental Neuroscience Branch (PDN) at the National Institute of Mental Health (NIMH) and other collaborative investigations. This protocol will be the entry point for all PDN investigations. Since the entry criteria for these protocols vary, the screening evaluations will also vary. Behavioral evaluations will also be done through this protocol for individuals participating in IRB-approved protocols being conducted by collaborating scientists in NIH. The evaluations might include: a psychiatric interview; a diagnostic interview; developmental and/or cognitive testing; ratings of other psychiatric symptoms; neuropsychological testing; a medical history; a physical exam; blood; and a request for medical records. Parents of minors will be interviewed. Upon conclusion of the screening process, subjects seeking eligibility for PDN protocols will either be offered participation in a research protocol and will sign the appropriate informed consent, or will be considered not appropriate for participation in research and will be discharged from the protocol.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00271622
|Contact: Margaret J Pekar||(301) firstname.lastname@example.org|
|Contact: Audrey E Thurm, Ph.D.||(301) email@example.com|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 firstname.lastname@example.org|
|Principal Investigator:||Audrey E Thurm, Ph.D.||National Institute of Mental Health (NIMH)|